{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:24:18Z","timestamp":1787127858162,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ajg.2026.02.009","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T19:51:40Z","timestamp":1777060300000},"page":"443-447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myelin-oligodendrocyte glycoprotein antibody-associated disease in Crohn\u2019s disease: an exceptional neurological manifestation"],"prefix":"10.1016","volume":"27","author":[{"given":"Meriem","family":"Charifi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Rechach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahrez","family":"Fissah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8993-6603","authenticated-orcid":false,"given":"Lamia","family":"Bengherbia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ouamer","family":"Belkacemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Kesraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahcene","family":"Chibane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajg.2026.02.009_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117426","article-title":"Neurology of inflammatory bowel disease","volume":"424","author":"Ferro","year":"2021","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ajg.2026.02.009_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1260358","article-title":"Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide","volume":"14","author":"Hor","year":"2023","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.ajg.2026.02.009_b0015","doi-asserted-by":"crossref","first-page":"e649","DOI":"10.1212\/NXI.0000000000000649","article-title":"Frequency of myelin oligodendrocyte glycoprotein antibody in multiple sclerosis: a multicenter cross-sectional study","volume":"7","author":"Cobo-Calvo","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"10.1016\/j.ajg.2026.02.009_b0020","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","article-title":"Myelin-oligodendrocyte glycoprotein antibody-associated disease","volume":"20","author":"Marignier","year":"2021","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.ajg.2026.02.009_b0025","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/jnnp-2022-330360","article-title":"Time to steroids impacts visual outcome of optic neuritis in MOGAD","volume":"94","author":"Rode","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ajg.2026.02.009_b0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.msard.2019.02.023","article-title":"Clinical characteristics of myelin oligodendrocyte glycoprotein antibody neuromyelitis optica spectrum disorder","volume":"30","author":"Salama","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.ajg.2026.02.009_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.msard.2018.12.006","article-title":"First report of coexistence of MOG-antibody-positive disease and Crohn\u2019s disease","volume":"28","author":"Philippart","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.ajg.2026.02.009_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102729","article-title":"FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES) unmasked by withdrawal of immunosuppression for Crohn\u2019s disease?","volume":"48","author":"Stamenova","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"10.1016\/j.ajg.2026.02.009_b0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1148\/radiology.139.2.7220891","article-title":"Ultrasound examination of the hydatic liver","volume":"139","author":"Gharbi","year":"1981","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.ajg.2026.02.009_b0050","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ajg.2026.02.009_b0055","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J Neuroinflamm"},{"issue":"4","key":"10.1016\/j.ajg.2026.02.009_b0060","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult Scler J"},{"key":"10.1016\/j.ajg.2026.02.009_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1011579","article-title":"Myelitis features and outcomes in CNS demyelinating disorders: comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD","volume":"13","author":"Fadda","year":"2022","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.ajg.2026.02.009_b0070","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/1352458516663853","article-title":"The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates","volume":"23","author":"Hamid","year":"2017","journal-title":"Mult Scler J"},{"issue":"19","key":"10.1016\/j.ajg.2026.02.009_b0075","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/WNL.0000000000002655","article-title":"Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder","volume":"86","author":"Hyun","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ajg.2026.02.009_b0080","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ajg.2026.02.009_b0085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.ajg.2026.02.009_b0090","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1148\/radiology.195.3.7754002","article-title":"Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters","volume":"195","author":"Tartaglino","year":"1995","journal-title":"Radiology"},{"issue":"21","key":"10.1016\/j.ajg.2026.02.009_b0095","doi-asserted-by":"crossref","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ajg.2026.02.009_b0100","doi-asserted-by":"crossref","DOI":"10.1177\/20552173211022767","article-title":"Frequency of myelin oligodendrocyte glycoprotein antibodies in a large cohort of neurological patients","volume":"7","author":"Held","year":"2021","journal-title":"Multiple Sclerosis J-Exp Transl Clin"},{"key":"10.1016\/j.ajg.2026.02.009_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.885218","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management","volume":"13","author":"Sechi","year":"2022","journal-title":"Front Neurol"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197926000377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197926000377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T07:26:32Z","timestamp":1787124392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197926000377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1687197926000377"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2026.02.009","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myelin-oligodendrocyte glycoprotein antibody-associated disease in Crohn\u2019s disease: an exceptional neurological manifestation","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2026.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}